Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $19.29 USD
Change Today -0.33 / -1.68%
Volume 266.5K
AXDX On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 4:30 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

accelerate diagnostics inc (AXDX) Snapshot

Open
$19.36
Previous Close
$19.62
Day High
$19.96
Day Low
$19.23
52 Week High
07/23/15 - $31.29
52 Week Low
09/22/14 - $16.31
Market Cap
862.7M
Average Volume 10 Days
221.2K
EPS TTM
$-0.63
Shares Outstanding
44.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ACCELERATE DIAGNOSTICS INC (AXDX)

Related News

No related news articles were found.

accelerate diagnostics inc (AXDX) Related Businessweek News

No Related Businessweek News Found

accelerate diagnostics inc (AXDX) Details

Accelerate Diagnostics, Inc., an in vitro diagnostics company, focuses on developing and commercializing solutions for the diagnosis of serious infections. The company is developing ID/AST System, a rapid diagnostic platform for the diagnosis of infectious pathogens. It also develops and licenses OptiChem surface coatings for use in microarraying components. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was founded in 1982 and is headquartered in Tucson, Arizona.

73 Employees
Last Reported Date: 02/26/15
Founded in 1982

accelerate diagnostics inc (AXDX) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $300.0K
Chief Financial Officer, Chief Accounting Off...
Total Annual Compensation: $186.2K
Chief Culture Officer and Head of Human Resou...
Total Annual Compensation: $237.5K
Compensation as of Fiscal Year 2014.

accelerate diagnostics inc (AXDX) Key Developments

Accelerate Diagnostics, Inc. Presents at 35th Annual Canaccord Genuity Growth Conference, Aug-13-2015 08:00 AM

Accelerate Diagnostics, Inc. Presents at 35th Annual Canaccord Genuity Growth Conference, Aug-13-2015 08:00 AM. Venue: InterContinental Boston, 510 Atlantic Avenue, Boston, MA 02210, United States. Speakers: Lawrence Mehren, Chief Executive Officer, President and Director.

Accelerate Diagnostics, Inc. Provides Clinical Trial Update on its Preclinical Study

Accelerate Diagnostics, Inc. has initiated enrollment at 8 clinical trial sites for its preclinical study. Upon successful completion the FDA registration trial will begin. Given the aforementioned progress, the company maintains its expectation that it will launch an FDA cleared product in the United States in the first half of 2016.

Accelerate Diagnostics, Inc. Announces Executive Changes

Accelerate Diagnostics, Inc. announced that it has appointed Ron Price as Senior Vice President and Head of Commercial Operations for the Americas. Mr. Price will replace Pete Bantock who is moving to the newly created position of Chief Culture Officer and Head of Human Resources. Mr. Price brings over 20 years of commercial operations experience and a proven track record of leading sales and marketing teams to achieve double-digit revenue growth and strong bottom-line performance. He joins Accelerate from Roche Diagnostics where he held the position of Vice President, Point of Care, Commercial Operations.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AXDX:US $19.29 USD -0.33

AXDX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AXDX.
View Industry Companies
 

Industry Analysis

AXDX

Industry Average

Valuation AXDX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6,666.8x
Price/Book 17.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 6,295.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACCELERATE DIAGNOSTICS INC, please visit www.acceleratediagnostics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.